Acute Coronary Syndromes A Companion to Braunwald's Heart Disease
Pierre Theroux
Acute Coronary Syndromes A Companion to Braunwald's Heart Disease - 2nd edition - 1600 John F. Kennedy Blvd. Ste 1800 Philadelphia, PA 19103-289 Elsevier Health Sciences 2010 - 448 pages
Contents:
The Past the Present the Future
Risk Factors Predicting Nonfatal Myocardial Infarction The INTERHEART Study
Results from the Reduction of Atherothrombosis for Continued Health REACH Registry
Historical Perspective and Lessons Learned from the Euro Heart Surveys on Acute Coronary Syndromes
Acute Coronary Syndrome in North America
Pathogenesis of Stable and Acute Coronary Syndromes
Molecular Mechanisms of the Acute Coronary Syndromes The Roles of Inflammation and Immunity
The Immune System in Acute Coronary Syndrome
Antiplatelet Therapy
Nonresponsiveness to Antiplatelet Therapy
Anticoagulants
Beta Blockers Calcium Channel Blockers Ranolazine Nitrates and Nitric Oxide Donors Use in Acute Coronary Syndromes
Adenosine TriphosphateSensitive Potassium Channels Adenosine and Preconditioning
Inflammation and Immunity as Targets for Drug Therapy in Acute Coronary Syndrome
Plaque Passivation and Endothelial Therapy
Revascularization in NonSTSegment Elevation Acute Coronary SyndromeFor Whom When and How?
Myocardial Cell Death and Regeneration
Pharmacogenomics
Clinical Recognition of Acute Coronary Syndromes
Biomarkers in Acute Ischemic Heart Disease
Prognostic Risk Stratification After Acute Coronary Syndromes The Role of Noninvasive Testing
Echocardiography in Acute Coronary Syndromes
Nuclear Cardiology Techniques in Acute Coronary Syndromes
Multislice Computed Tomography in Acute Coronary Syndromes
Emerging Diagnostic Procedures for the Vulnerable Plaque
Risk Stratification in Unstable Angina and NonSTSegment Elevation Myocardial Infarction
Treatment Principles and Emerging Therapies in Acute Coronary Syndromes without STSegment Elevation
Percutaneous Coronary Intervention and Concomitant Antithrombotic Therapy
Bleeding in the Acute Coronary Syndromes
The Patient with Disabling Refractory Angina Not Amenable to Revascularization Procedures
Dietary Intervention in Coronary Care Units and in Secondary Prevention
Exercise Training After an Acute Coronary Syndrome
Diagnosis and Treatment of NonSTSegment Elevation Acute Coronary Syndromes European Society of Cardiology Guidelines
ACCAHA 2007 Guidelines for the Management of Patients with Unstable AnginaNonSTSegment Elevation Myocardial Infarction A Summary Article
The Modern Cardiac Care Unit
Index
Acute Coronary Syndromes—a Companion to Braunwald’s Heart Disease—covers the state-of-the-art scientific and clinical information you need to rapidly evaluate and manage acute coronary syndromes. Dr. Pierre Theroux and his team of expert contributors present advances in diagnostic and imaging techniques such as biomarkers, nuclear cardiology, echocardiography, and multislice CT; secondary prevention; and new antiplatelet, anti-ischemic, and gene therapies.
Tap into the most definitive knowledge available from one of the leading experts in the field and a stellar cast of contributors.
Understand the special considerations for the care of acute coronary syndromes in the emergency department and the coronary care unit.
Effectively handle the treatment of special populations and chronic patients thanks to coverage of these challenges
See techniques and procedures in greater detail and clarity through the all-new full-color design.
Approach treatment with a global perspective from the new section on Population-Based Perspective that discusses the INTERHEART study, insights from the REACH registry, lessons learned from European registries, and ACS in North America.
Gain a comprehensive understanding of ACS through coverage of pathophysiology, molecular mechanisms, the role of the immune system, and brand-new chapters on cell necrosis and cell regeneration and pharmacogenetics in the section on Disease-Based Perspectives.
Integrate the latest testing and treatment techniques into your practice thanks to new chapters on biomarkers in acute ischemic heart disease; the role of noninvasive testing in prognostic risk stratification; the culprit lesions and patient at risk; non-responsiveness to antiplatelet therapy; bleeding in the acute coronary syndromes; and the refractory patient.
1437721494 9781437721492 = activation acute coronary syndromes acute myocardial infarction addition agents antiplatelet aspirin assessment associated atherosclerosis benefit bleeding blood cardiac Cardiol cardiovascular cause cells chest pain Circulation clinical clopidogrel Coll Cardiol compared controlled coronary artery disease death diabetes dose drug early effects elevation endothelial Engl et al evaluation evidence exercise factor failure function guidelines Heart heparin higher hospital human IIb/IIIa imaging important improved increased inflammatory inhibition inhibitors initial intervention invasive ischemia ischemic less levels lower major markers measured months mortality observed outcome patients with acute percutaneous plaque platelet predict present primary protein randomized recent receptor recommended reduced reperfusion reperfusion injury reported response revascularization risk role score severe showed shown significant STEMI stent strategy stress suggest testing therapy tion tissue treated treatment trial troponin undergoing unstable angina vascular versus
--Acute Coronary Syndrome.-- Medical › Cardiology-- Medical / Cardiology
RC685.C6A288 2011 WG 300 A185884 2011
616.1′23 THE
Acute Coronary Syndromes A Companion to Braunwald's Heart Disease - 2nd edition - 1600 John F. Kennedy Blvd. Ste 1800 Philadelphia, PA 19103-289 Elsevier Health Sciences 2010 - 448 pages
Contents:
The Past the Present the Future
Risk Factors Predicting Nonfatal Myocardial Infarction The INTERHEART Study
Results from the Reduction of Atherothrombosis for Continued Health REACH Registry
Historical Perspective and Lessons Learned from the Euro Heart Surveys on Acute Coronary Syndromes
Acute Coronary Syndrome in North America
Pathogenesis of Stable and Acute Coronary Syndromes
Molecular Mechanisms of the Acute Coronary Syndromes The Roles of Inflammation and Immunity
The Immune System in Acute Coronary Syndrome
Antiplatelet Therapy
Nonresponsiveness to Antiplatelet Therapy
Anticoagulants
Beta Blockers Calcium Channel Blockers Ranolazine Nitrates and Nitric Oxide Donors Use in Acute Coronary Syndromes
Adenosine TriphosphateSensitive Potassium Channels Adenosine and Preconditioning
Inflammation and Immunity as Targets for Drug Therapy in Acute Coronary Syndrome
Plaque Passivation and Endothelial Therapy
Revascularization in NonSTSegment Elevation Acute Coronary SyndromeFor Whom When and How?
Myocardial Cell Death and Regeneration
Pharmacogenomics
Clinical Recognition of Acute Coronary Syndromes
Biomarkers in Acute Ischemic Heart Disease
Prognostic Risk Stratification After Acute Coronary Syndromes The Role of Noninvasive Testing
Echocardiography in Acute Coronary Syndromes
Nuclear Cardiology Techniques in Acute Coronary Syndromes
Multislice Computed Tomography in Acute Coronary Syndromes
Emerging Diagnostic Procedures for the Vulnerable Plaque
Risk Stratification in Unstable Angina and NonSTSegment Elevation Myocardial Infarction
Treatment Principles and Emerging Therapies in Acute Coronary Syndromes without STSegment Elevation
Percutaneous Coronary Intervention and Concomitant Antithrombotic Therapy
Bleeding in the Acute Coronary Syndromes
The Patient with Disabling Refractory Angina Not Amenable to Revascularization Procedures
Dietary Intervention in Coronary Care Units and in Secondary Prevention
Exercise Training After an Acute Coronary Syndrome
Diagnosis and Treatment of NonSTSegment Elevation Acute Coronary Syndromes European Society of Cardiology Guidelines
ACCAHA 2007 Guidelines for the Management of Patients with Unstable AnginaNonSTSegment Elevation Myocardial Infarction A Summary Article
The Modern Cardiac Care Unit
Index
Acute Coronary Syndromes—a Companion to Braunwald’s Heart Disease—covers the state-of-the-art scientific and clinical information you need to rapidly evaluate and manage acute coronary syndromes. Dr. Pierre Theroux and his team of expert contributors present advances in diagnostic and imaging techniques such as biomarkers, nuclear cardiology, echocardiography, and multislice CT; secondary prevention; and new antiplatelet, anti-ischemic, and gene therapies.
Tap into the most definitive knowledge available from one of the leading experts in the field and a stellar cast of contributors.
Understand the special considerations for the care of acute coronary syndromes in the emergency department and the coronary care unit.
Effectively handle the treatment of special populations and chronic patients thanks to coverage of these challenges
See techniques and procedures in greater detail and clarity through the all-new full-color design.
Approach treatment with a global perspective from the new section on Population-Based Perspective that discusses the INTERHEART study, insights from the REACH registry, lessons learned from European registries, and ACS in North America.
Gain a comprehensive understanding of ACS through coverage of pathophysiology, molecular mechanisms, the role of the immune system, and brand-new chapters on cell necrosis and cell regeneration and pharmacogenetics in the section on Disease-Based Perspectives.
Integrate the latest testing and treatment techniques into your practice thanks to new chapters on biomarkers in acute ischemic heart disease; the role of noninvasive testing in prognostic risk stratification; the culprit lesions and patient at risk; non-responsiveness to antiplatelet therapy; bleeding in the acute coronary syndromes; and the refractory patient.
1437721494 9781437721492 = activation acute coronary syndromes acute myocardial infarction addition agents antiplatelet aspirin assessment associated atherosclerosis benefit bleeding blood cardiac Cardiol cardiovascular cause cells chest pain Circulation clinical clopidogrel Coll Cardiol compared controlled coronary artery disease death diabetes dose drug early effects elevation endothelial Engl et al evaluation evidence exercise factor failure function guidelines Heart heparin higher hospital human IIb/IIIa imaging important improved increased inflammatory inhibition inhibitors initial intervention invasive ischemia ischemic less levels lower major markers measured months mortality observed outcome patients with acute percutaneous plaque platelet predict present primary protein randomized recent receptor recommended reduced reperfusion reperfusion injury reported response revascularization risk role score severe showed shown significant STEMI stent strategy stress suggest testing therapy tion tissue treated treatment trial troponin undergoing unstable angina vascular versus
--Acute Coronary Syndrome.-- Medical › Cardiology-- Medical / Cardiology
RC685.C6A288 2011 WG 300 A185884 2011
616.1′23 THE